FdaApplication
NDA 217388
Identifiers
- fda_app_no: NDA217388
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2023-12-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WAINUA | EPLONTERSEN SODIUM | EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML) | SOLUTION;SUBCUTANEOUS |
| WAINUA (AUTOINJECTOR) | EPLONTERSEN SODIUM | EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML) | SOLUTION;SUBCUTANEOUS |
2 products